Allogeneic Therapy Segment Held Largest Share of Middle East and Africa Cell therapy Market in 2019
According to our new market research study on “Middle East and Africa Cell therapy Market to 2027 - Regional Analysis and Forecast - by ingredient type, indication, and forms,” the market is expected to reach US$ 346.7 million by 2027 from US$ 234.4 million in 2019; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027. The report provides trends prevailing in the Middle East and Africa Cell therapy market, and drivers and restraints pertaining to the market growth.
The Middle East and Africa Cell therapy market based on therapy type is segmented into Allogeneic, Autologous. In 2019, the allogeneic segment accounted for the largest share of the Middle East and Africa Cell therapy market. The growth of the market for this segment is attributed to increasing Number of product launch to accelerate the overall product demand for stem therapy using allogeneic stem cell therapeutics. However, the Autologous segment is likely register the highest CAGR in the market during the forecast period.
The growth of the Middle East and Africa Cell therapy market is mainly attributed to Increasing Prevalence of Chronic Diseases, Rising Adoption of Regenerative Medicines and Increasing Number of Approvals for Cell-Based Therapies. However, high costs of cell therapy manufacturing is the major factor hindering the market growth in Middle East and Africa.
A few of the leading companies operating in the Middle East and Africa Cell therapy market are NuVasive, Inc., Smith & Nephew, Bristol-Myers Squibb Company and others.
The report segments Middle East and Africa Cell therapy market as follows:
Middle East and Africa Cell therapy Market - By Therapy Type
Middle East and Africa Cell therapy Market - By Product
Middle East and Africa Cell therapy Market - By Technology
Middle East and Africa Cell therapy Market - By Application
Middle East and Africa Cell therapy Market - By End user
Middle East and Africa Cell therapy Market - By Country
Reasons to Buy
It provides understanding of the Middle East and Africa, cell therapy market landscape and identifies cell therapy market segments that are most likely to guarantee a strong return.It guides
Stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East and Africa cell therapy market.It helps
Efficiently plan merger and acquisition, and partnership deals in the cell therapy market by identifying market segments with the most promising probable sales.
It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cell therapy market performance of various segments pertaining to the Middle East and Africa cell therapy market.
It provides cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.
According to our new market research study on “Middle East and Africa Cell therapy Market to 2027 - Regional Analysis and Forecast - by ingredient type, indication, and forms,” the market is expected to reach US$ 346.7 million by 2027 from US$ 234.4 million in 2019; it is estimated to grow at a CAGR of 5.1% from 2020 to 2027. The report provides trends prevailing in the Middle East and Africa Cell therapy market, and drivers and restraints pertaining to the market growth.
The Middle East and Africa Cell therapy market based on therapy type is segmented into Allogeneic, Autologous. In 2019, the allogeneic segment accounted for the largest share of the Middle East and Africa Cell therapy market. The growth of the market for this segment is attributed to increasing Number of product launch to accelerate the overall product demand for stem therapy using allogeneic stem cell therapeutics. However, the Autologous segment is likely register the highest CAGR in the market during the forecast period.
The growth of the Middle East and Africa Cell therapy market is mainly attributed to Increasing Prevalence of Chronic Diseases, Rising Adoption of Regenerative Medicines and Increasing Number of Approvals for Cell-Based Therapies. However, high costs of cell therapy manufacturing is the major factor hindering the market growth in Middle East and Africa.
A few of the leading companies operating in the Middle East and Africa Cell therapy market are NuVasive, Inc., Smith & Nephew, Bristol-Myers Squibb Company and others.
The report segments Middle East and Africa Cell therapy market as follows:
Middle East and Africa Cell therapy Market - By Therapy Type
- Allogeneic
- Autologous
Middle East and Africa Cell therapy Market - By Product
- Consumables
- Equipment
- Systems and Software
Middle East and Africa Cell therapy Market - By Technology
- Viral Vector Technology
- Genome Editing Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Cell Plasticity Technology
- Three-dimensional Technology
Middle East and Africa Cell therapy Market - By Application
- Oncology
- Cardiovascular
- Orthopedic
- Wound Management
- Other Applications
Middle East and Africa Cell therapy Market - By End user
- Research Institutes
- Hospitals
- Others
Middle East and Africa Cell therapy Market - By Country
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
Reasons to Buy
It provides understanding of the Middle East and Africa, cell therapy market landscape and identifies cell therapy market segments that are most likely to guarantee a strong return.It guides
Stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East and Africa cell therapy market.It helps
Efficiently plan merger and acquisition, and partnership deals in the cell therapy market by identifying market segments with the most promising probable sales.
It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cell therapy market performance of various segments pertaining to the Middle East and Africa cell therapy market.
It provides cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.
Table of Contents
1. Introduction
3. Research Methodology
4. Middle East and Africa Cell Therapy Market - Market Landscape
5. Middle East and Africa Cell Therapy Market - Key Market Dynamics
6. Cell Therapy Market - Middle East and Africa Analysis
7. Middle East and Africa Cell Therapy Market Analysis - By Therapy Type
8. Middle East and Africa Cell Therapy Market Analysis - By Product
9. Middle East and Africa Cell Therapy Market Analysis - By Technology
10. Middle East and Africa cell therapy market Analysis - By Application
11. Middle East and Africa cell therapy market Analysis - By End User
12. Middle East and Africa Cell Therapy Market Analysis And Forecasts To 2027 - Regional Analysis
13. Impact of COVID-19 Pandemic on Middle East and Africa Cell Therapy Market
14. Company Profiles
15. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- NuVasive, Inc.
- Smith & Nephew
- Bristol-Myers Squibb Company
